Abbott Laboratories (ABT) plans to raise $20 billion through a bond sale in the United States. This funding is intended to finance its acquisition of Exact Sciences. The company has filed for an eight-part notes offering, though the specific size of this offering has not been disclosed.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Key facts: Abbott Laboratories to raise $20 billion via bond sale; files for notes offering
Abbott Laboratories (ABT) plans to raise $20 billion through a bond sale in the United States. This funding is intended to finance its acquisition of Exact Sciences. The company has filed for an eight-part notes offering, though the specific size of this offering has not been disclosed.